Across states having legalized medical cannabis, pain is the most widely cited condition for its use.
Among five key state programs, nearly 90% of registered medical cannabis patients report chronic or severe pain as the primary illness being treated.
Pain, post-traumatic stress disorder (PTSD), and muscle spasticity, respectively, are the top three most commonly cited conditions reported by patients seeking medical cannabis use.
Patient-reported efficacy of cannabis is leading a growing number of consumers to substitute pharmaceuticals — including opioids — for medical cannabis.
In markets featuring low barriers to patient entry and physicians can prescribe for any condition, the percentages of cases citing pain or anxiety are likely to be high.
In the first year of its program, the Oklahoma Medical Marijuana Authority has enrolled more than 3.5% of the state’s population as patients; the agency attributes the stronger-than-expected participation rate to minimal financial obstacles and the lack of qualifying restrictions.